{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:57:14Z","timestamp":1782273434778,"version":"3.54.5"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.4732","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T19:46:29Z","timestamp":1617824789000},"page":"e214732","source":"Crossref","is-referenced-by-count":43,"title":["Comparison of Clinical Characteristics Between Clinical Trial Participants and Nonparticipants Using Electronic Health Record Data"],"prefix":"10.1001","volume":"4","author":[{"given":"James R.","family":"Rogers","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hripcsak","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"},{"name":"Medical Informatics Services, New York\u2013Presbyterian Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Kuen","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"issue":"9453","key":"zoi210168r1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"zoi210168r2","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.2055","article-title":"Factors associated with age disparities among cancer clinical trial participants.","author":"Ludmir","year":"2019","journal-title":"JAMA Oncol"},{"key":"zoi210168r3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"issue":"3","key":"zoi210168r4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju002","article-title":"Comparison of survival outcomes among cancer patients treated in and out of clinical trials.","volume":"106","author":"Unger","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"zoi210168r5","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities.","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"zoi210168r6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/archinte.167.1.68","article-title":"External validity of clinical trials in acute myocardial infarction.","volume":"167","author":"Steg","year":"2007","journal-title":"Arch Intern Med"},{"issue":"10","key":"zoi210168r7","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamainternmed.2019.1501","article-title":"Representativeness of randomized clinical trial cohorts in end-stage kidney disease: a meta-analysis.","volume":"179","author":"Smyth","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi210168r8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.v181.6","article-title":"A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.","volume":"181","author":"Yiu","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"zoi210168r9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/dom.2019.21.issue-4","article-title":"How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? a large European observational study.","volume":"21","author":"Birkeland","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"zoi210168r10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.5414\/CP203285","article-title":"Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings.","volume":"56","author":"Kostev","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"zoi210168r11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/jamia\/ocaa224","article-title":"Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.","volume":"28","author":"Rogers","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"zoi210168r12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/cts.v13.4","article-title":"Clinical trial generalizability assessment in the big data era: a review.","volume":"13","author":"He","year":"2020","journal-title":"Clin Transl Sci"},{"key":"zoi210168r14","first-page":"574","article-title":"Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers.","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"issue":"3","key":"zoi210168r15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033677","article-title":"The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.","volume":"7","author":"Tasneem","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"zoi210168r17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/sim.6058","article-title":"Metrics for covariate balance in cohort studies of causal effects.","volume":"33","author":"Franklin","year":"2014","journal-title":"Stat Med"},{"issue":"25","key":"zoi210168r18","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"22","key":"zoi210168r20","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1161\/CIRCULATIONAHA.118.039180","article-title":"Representation of patients with cardiovascular disease in pivotal cancer clinical trials.","volume":"139","author":"Bonsu","year":"2019","journal-title":"Circulation"},{"issue":"15","key":"zoi210168r21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies.","volume":"375","author":"Moslehi","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi210168r22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1171","article-title":"Researchers\u2019, regulators\u2019, and sponsors\u2019 views on pediatric clinical trials: a multinational study.","volume":"138","author":"Joseph","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi210168r23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children.","volume":"79","author":"Joseph","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"zoi210168r24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2125.2000.00125.x","article-title":"Drug trials in children: problems and the way forward.","volume":"49","author":"Conroy","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"zoi210168r25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cct.2016.01.009","article-title":"Innovations for phase I dose-finding designs in pediatric oncology clinical trials.","volume":"47","author":"Doussau","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"zoi210168r26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1634\/theoncologist.12-11-1336","article-title":"Ethical challenges in cancer research in children.","volume":"12","author":"Berg","year":"2007","journal-title":"Oncologist"},{"issue":"4","key":"zoi210168r27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities.","volume":"56","author":"Cheung","year":"2000","journal-title":"Biometrics"},{"issue":"12","key":"zoi210168r28","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/sim.6097","article-title":"Phase I\/II adaptive design for drug combination oncology trials.","volume":"33","author":"Wages","year":"2014","journal-title":"Stat Med"},{"issue":"3","key":"zoi210168r29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/hep.v59.3","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"zoi210168r30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/2396987318825484","article-title":"Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke.","volume":"4","author":"Sexton","year":"2019","journal-title":"Eur Stroke J"},{"issue":"4","key":"zoi210168r31","article-title":"Physical rehabilitation approaches for the recovery of function and mobility following stroke.","author":"Pollock","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"zoi210168r32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi210168r33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","article-title":"Secondary stroke prevention.","volume":"13","author":"Hankey","year":"2014","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi210168r34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1212\/WNL.0b013e3181ca9cff","article-title":"A score to predict early risk of recurrence after ischemic stroke.","volume":"74","author":"Ay","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"zoi210168r35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.119.043594","article-title":"Women\u2019s participation in cardiovascular clinical trials from 2010 to 2017.","volume":"141","author":"Jin","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"zoi210168r36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6700","article-title":"Quantifying sex bias in clinical studies at scale with automated data extraction.","volume":"2","author":"Feldman","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"18","key":"zoi210168r37","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs.","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"zoi210168r38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/archinte.167.9.905","article-title":"Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.","volume":"167","author":"Ding","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"zoi210168r39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/amiajnl-2011-000681","article-title":"Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.","volume":"20","author":"Weiskopf","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"zoi210168r40","doi-asserted-by":"publisher","first-page":"k1452","DOI":"10.1136\/bmj.k1452","article-title":"How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider.","volume":"361","author":"Tse","year":"2018","journal-title":"BMJ"},{"key":"zoi210168r13","unstructured":"Observational Health Data Sciences and Informatics. CommonDataModel: definition and DDLs for the OMOP Common Data Model (CDM). 2018. Accessed January 5, 2018. https:\/\/github.com\/OHDSI\/CommonDataModel"},{"key":"zoi210168r16","unstructured":"Observational Health Data Sciences and Informatics. Github: OHDSI\/FeatureExtraction. 2020. Accessed December 30, 2020. https:\/\/github.com\/OHDSI\/FeatureExtraction"},{"key":"zoi210168r19","unstructured":"Github. Tidyverse\/Ggplot2: tidyverse. 2020. Accessed September 30, 2020. https:\/\/github.com\/tidyverse\/ggplot2"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2778202\/rogers_2021_oi_210168_1617121210.95213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T19:46:47Z","timestamp":1617824807000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2778202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4732","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}